28th IABCR/Breakthrough Breast Cancer Conference
Stromal-epithelial interactions in breast cancer development and progression
15-18 April 2012, Palace Hotel, Manchester, UK
Welcome
The Conference will encompass breast cancer development and progression with an emphasis on the influence of the stromal environment. We aim to bring together cutting edge experts in these areas with young investigators to discuss the important role of stroma and its role in cellular adhesion, stem cell activity, migration and metastasis.
There will be sessions focused on breast cancer development, precursor lesions, invasive cancer and metastatic disease. The goal of the meeting will be to stimulate discussion that connects an understanding of stromal epithelial interactions with the alterations that occur during tumourigenic progression.
We will allot plenty of time for discussion to allow researchers to communicate their most recent data and diverse perspectives. Participation from post-doctoral scientists and graduate students will be encouraged through the selection of short talks from submitted abstracts and the ample time set aside for poster sessions.
The overall objective is to highlight the potential that targeting the stromal environment will have for improving breast cancer treatment.
Latest News
RCP Accreditation
The 28th IABCR/Breakthrough Breast Cancer Conference has been accredited by the Royal College of Physicians (RCP) and has been awarded 17 Continuing Professional Development (CPD) credits.
Conference Themes
The themes of the meeting will be stem cells, metastasis and tumour-stroma interactions, with an emphasis on model systems and mechanisms.
Keynote Speaker: Mina Bissell
Mina Bissell has been recognised for her lifetime contributions to the fields of breast cancer research, the enhanced role of extracellular matrix (ECM) and the nucleus environment to gene expression in normal and malignant tissues. These works have ushered and have changed some central paradigms that have strengthened the importance of context in the development of cancer. Mina has recently been awarded the 2011 Breast Cancer Research Foundation Jill Rose Award for distinguished biomedical research.
Keynote Speaker: Max Wicha
Professor Max Wicha is Director of the University of Michigan Comprehensive Cancer Center and is known for his research in the field of breast oncology, particularly the study of how breast cancer cells grow and metastasize. His lab was part of the team that first discovered stem cells in breast cancer, the first described in any human solid tumour. Professor Wicha is one of the leading experts on cancer stem cells, with his continued work on breast cancer stem cells. He is also active as a clinician, specialising in the treatment of breast cancer patients.
Confirmed Speakers
- Fariba Behbod, The University of Kansas, USA
- Mina Bissell, Lawrence Berkeley National Laboratory, USA
- Michael Clarke, Stanford Institute for Stem Cell Biology & Regenerative Medicine, USA
- Jack Cuzick, Wolfson Institute of Preventive Medicine, London, UK
- Janine Erler, Biotech Research and Innovation Centre, University of Copenhagen, Denmark
- Gillian Farnie, The University of Manchester, UK
- Eva Gonzalez-Suarez, Cancer Epigenetics and Biology Program, Barcelona, Spain
- Tony Howell, Breakthrough Unit, The University of Manchester, UK
- Kent Hunter, National Cancer Institute, Bethesda, USA
- Clare Isacke, The Institute of Cancer Research, UK
- Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands
- Christoph Klein, University of Regensburg, Germany
- Göran Landberg, Breakthrough Unit, The University of Manchester, UK
- Michael Lisanti, Breakthrough Unit, The University of Manchester, UK
- Paul Lu, Breakthrough Unit, The University of Manchester, UK
- William Muller, McGill University, Montréal, Canada
- Chris Ormandy, Garvan Institute, Sydney, Australia
- Arne Östman, Karolinska Institute, Stockholm, Sweden
- Jeff Rosen, Baylor College of Medicine, Houston, USA
- Erik Sahai, CR-UK London Research Institute, UK
- Pepper Schedin, University of Colorado, Denver, USA
- Thea Tlsty, University of California, San Francisco, USA
- Zena Werb, University of California, San Francisco, USA
- Max Wicha, University of Michigan, USA